This is the Scientific Surgery Archive, which contains all randomized clinical trials in surgery that have been identified by searching the top 50 English language medical journal issues since January 1998. Compiled by Jonothan J. Earnshaw, former Editor-in-Chief, BJS

Effect of statins on proteolytic activity in the wall of abdominal aortic aneurysms. BJS 2008; 95: 333-337.

Published: 29th October 2007

Authors: S. Abisi, K. G. Burnand, J. Humphries, M. Waltham, P. Taylor, A. Smith et al.

Background

The aim of this study was to examine the effect of statin treatment on the activity of proteases in the wall of abdominal aortic aneurysms (AAAs).

Method

The activities of matrix metalloproteinases (MMPs) 9 and 3, cathepsins B, H, K, L and S, and the cystatin C level were measured in extracts of AAA wall taken from 82 patients undergoing AAA repair; 21 patients were receiving statin treatment before surgery. All values were standardized against soluble protein (SP) concentration in the extract, and reported as median (interquartile range) or mean(s.e.m.).

Results

The two groups had similar demographics. Reduced activity of MMP‐9 (43 (34–56) versus 80 (62–110) pg per mg SP; P < 0·001), cathepsin H (183 (117–366) versus 321 (172–644) nmol 4‐methylcoumarin‐7‐amide released per mg SP; P = 0·016) and cathepsin L (102 (51–372) versus 287 (112–816) µmol 7‐amino‐4‐trifluoromethylcoumarin released per mg SP; P = 0·020) was found in the statin‐treated aortas compared with AAAs from patients not taking a statin. The statin‐treated group had lower MMP‐3 activity, but this did not reach statistical significance (P = 0·053). Cystatin C levels were higher in statin‐treated aortas than in controls (41·3(3·1) versus 28·9(2·1) ng per mg SP; P = 0·003).

Conclusion

Full text